American Financial Advisors LLC Sells 6,930 Shares of SPDR S&P Biotech ETF (NYSEARCA:XBI)

American Financial Advisors LLC lessened its holdings in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 9.1% during the fourth quarter, HoldingsChannel.com reports. The firm owned 69,185 shares of the exchange traded fund’s stock after selling 6,930 shares during the quarter. SPDR S&P Biotech ETF makes up about 0.9% of American Financial Advisors LLC’s holdings, making the stock its 27th biggest holding. American Financial Advisors LLC’s holdings in SPDR S&P Biotech ETF were worth $6,178,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently made changes to their positions in the business. JPMorgan Chase & Co. grew its position in shares of SPDR S&P Biotech ETF by 179.1% during the 1st quarter. JPMorgan Chase & Co. now owns 7,534,471 shares of the exchange traded fund’s stock worth $574,202,000 after purchasing an additional 4,835,071 shares in the last quarter. Phoenix Holdings Ltd. boosted its position in shares of SPDR S&P Biotech ETF by 0.8% during the 3rd quarter. Phoenix Holdings Ltd. now owns 2,151,359 shares of the exchange traded fund’s stock worth $157,092,000 after acquiring an additional 17,221 shares in the last quarter. Healthcare of Ontario Pension Plan Trust Fund boosted its position in shares of SPDR S&P Biotech ETF by 103.3% during the 3rd quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 1,771,000 shares of the exchange traded fund’s stock worth $129,318,000 after acquiring an additional 900,000 shares in the last quarter. Jane Street Group LLC boosted its position in shares of SPDR S&P Biotech ETF by 315.1% during the 1st quarter. Jane Street Group LLC now owns 1,529,813 shares of the exchange traded fund’s stock worth $116,587,000 after acquiring an additional 1,161,234 shares in the last quarter. Finally, Migdal Insurance & Financial Holdings Ltd. acquired a new stake in shares of SPDR S&P Biotech ETF during the 3rd quarter worth approximately $102,900,000.

SPDR S&P Biotech ETF Stock Performance

Shares of NYSEARCA XBI traded down $0.65 during trading hours on Friday, hitting $82.83. 13,779,489 shares of the stock were exchanged, compared to its average volume of 11,741,763. SPDR S&P Biotech ETF has a 1-year low of $63.80 and a 1-year high of $103.52. The company has a market cap of $6.43 billion, a PE ratio of 11.47 and a beta of 1.08. The company’s fifty day simple moving average is $93.68 and its two-hundred day simple moving average is $84.12.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.